header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

O2484 A FIFTEEN YEAR REVIEW OF HYDROXYAPATITE CERAMIC COATED HIP IMPLANTS: A CLINICAL AND HISTOLOGICAL EVALUATION



Abstract

Aims: To ascertain whether or not Hydroxyapatite Ceramic coated implants (HAC) will survive more than ten years after implantation. Method: Since May 1988 HAC hip prostheses have been used in more than 1900 operations. The patients are assessed using the Harris Hip Score (HHS) pre- and postoperatively and then annually. Post mortem specimens are sectioned to study bone integration to the HAC. Initial X-rays are reviewed and followed by annual X-ray after þve years. Results: HHS indicates that the system works with only 7% scoring less than 90. Only seven hips had a deterioration in HHS associated with the implant including three with aseptic loosening. One had catastrophic third body wear in a plastic acetabular liner. Histology shows early bony bonding (six weeks) to HAC particularly in cancellous bone. The HAC coating behaves biologically and is ultimately replaced with bone with no intervening þbrous layer: a Perfect Fit (seen at variable times after six years)Conclusions: HAC hip prostheses provide a ten year, pain free arthroplasty. There is one case of polyethylene debris/granuloma disease. Maximum follow-up is þfteen years. Longer term results will be awaited with interest.

Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.